N02CM77007-98_Amendment_One.pdf
PDF 54 KB Posted
- Attached to
- Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies
- Solicitation number
- N02CM77007-98
About this file
Amendment One: The purpose of this amendment is to address a question received and to clarify language in Section A item 9 of the Request for Proposal.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| N02CM77007-98_Amendment_Two.pdf | ||
| RFP_N02CM77007-98_Solicitation_Final_03_03_17.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
RFP Number : N02CM77007-98 Amendment 1
- 1 -
OFFICE OF ACQUISITIONS
NATIONAL CANCER INSTITUTE
REQUEST FOR PROPOSAL NUMBER: N02CM77007-98
Amendment No.: 1
Date of Issuance: March 17, 2017
The above numbered Request For Proposal (RFP) is amended as set forth below. The hour and date specified for receipt of Offerors remains unchanged.
Offerors MUST acknowledge receipt of the amendment prior to the hour and the date specified in the solicitation or as amended, by separate letter, telegram, or Electronic Mail which includes a reference to the RFP and Amendment number(s). For your convenience, the Proposal Intent Response Form is provided in SECTION J - List of Attachments of this RFP, for this purpose.
FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERORS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.
This Amendment revises the RFP as stated below:
1. Section A item 9 of the Request for Proposal should state the following:
This solicitation requires delivery of proposals as stated in ATTACHMENT 1, "PACKAGING AND DELIVERY OF THE PROPOSAL." If proposals are required to be delivered to two different locations, the OFFICIAL POINT OF RECEIPT for determining TIMELY DELIVERY is the eCPS System. IF YOUR PROPOSAL IS NOT RECEIVED BY THE CONTRACTING OFFICER OR HIS DESIGNEE AT THE PLACE AND TIME in eCPS, THEN IT WILL BE CONSIDERED LATE AND HANDLED IN ACCORDANCE WITH subparagraph (c)(3) of FAR Clause 52.215-1, Instructions to Offerors--Competitive Acquisition," LOCATED IN SECTION L.1. OF THIS SOLICITATION.
2. Answer the following question:
Q: I looked through the attached document and cannot find the specific compounds the NIH is looking for? Can you tell me where I can find this information?
A: Please note that, compounds to be manufactured under this contract are unknown at this time and that will depend on the future needs of the program and the National Cancer Institute. Please refer to the statement of work for more information.
File details come from the government source that posted it. Updated .